Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 diabetics, a new study has found. It highlights the fundamental difference ...

A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...

Texas has one of the highest rates of diabetes in the country, with more than 2.7 million Texans diagnosed with the condition ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

Sulforaphane, a compound found in broccoli sprouts, may help lower blood sugar levels in people with prediabetes, a new study has found.

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

Researchers have developed a method using engineered blood vessel cells (R-VECs) to improve islet transplantation which could ...

Dear Savvy Senior, What can you tell me about service dogs for seniors with disabilities? My 67-year-old father has chronic ...